Vitamin D receptor: A new risk marker for clinical restenosis after percutaneous coronary intervention

Expert Opinion on Therapeutic Targets

Volumn 14, Issue 3, 2010, Pages 243-251

  Monraats, Pascalle S ^a,b   Fang, Yue ^c   Pons, Douwe ^a,b   Pires, Nuno M M ^a,d   Pols, Huibert A P ^e   Zwinderman, Aeilko H ^f   De Maat, Moniek P M ^e   Doevendans, Pieter A F ^g   Dewinter, Robbert J ^f   Tio, René A ^h   Waltenberger, Johannes ⁱ   Frants, Rune R ^a   Quax, Paul H A ^a   Van Der Laarse, Arnoud ^a   Van Der Wall, Ernst E ^a   Uitterlinden, André G ^e   Jukema, J Wouter ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d DEPARTMENT OF RESEARCH AND DEVELOPMENT   (Portugal)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁱ MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Genetics; Haplotype; Polymorphisms; Restenosis; Vitamin D receptor

Indexed keywords

CLOPIDOGREL; MARKER; TICLOPIDINE; VITAMIN D RECEPTOR;

ADULT; CLINICAL PRACTICE; CORONARY ARTERY BYPASS GRAFT; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; POPULATION; RESTENOSIS; REVASCULARIZATION; REVIEW; RISK FACTOR; SCREENING; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 77149120749     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728220903520929     Document Type: Review

References (27)

1. Uitterlinden AG, Fang Y, Van Meurs JB, et al. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004;338:143-156
2. van Etten E, Verlinden L, Giulietti A, et al. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol 2007;37:395-405
3. Wu-Wong JR, Nakane M, Ma J, et al. Effects of vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis 2006;186:20-28
4. Mathew S, Lund RJ, Chaudhary LR, et al. Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol 2008;19:1509-1519
5. Kastrati A, Schomig A, Elezi S, et al. Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesions. Circulation 1998;97:2396-2401
6. Mehilli J, Kastrati A, Bollwein H, et al. Gender and restenosis after coronary artery stenting. Eur Heart J 2003;24:1523-1530
7. Schomig A, Kastrati A, Elezi S, et al. Bimodal distribution of angiographic measures of restenosis six months after coronary stent placement. Circulation 1997;96:3880-3887
8. Weintraub WS, Kosinski AS, Brown CL III, King SB III. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol 1993;21:6-14
9. Monraats PS, Kurreeman FA, Pons D, et al. Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention. Genes Immun 2007;8:44-50
10. Ortlepp JR, Lauscher J, Hoffmann R, et al. The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabet Med 2001;18:842-845
11. Ortlepp JR, von Korff A, Hanrath P, et al. Vitamin D receptor gene polymorphism BsmI is not associated with the prevalence and severity of CAD in a large-scale angiographic cohort of 3441 patients. Eur J Clin Invest 2003;33:106-109
12. Pan XM, Li DR, Yang L, et al. No association between vitamin D receptor polymorphisms and coronary artery disease in a Chinese population. DNA Cell Biol 2009;28:521-525
13. Fang Y, Van Meurs JB, d'Alesio A, et al. Promoter and 3¢-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam study. Am J Hum Genet 2005;77:807-823
14. Arai H, Miyamoto KI, Yoshida M, et al. The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. J Bone Miner Res 2001;16:1256-1264
15. Gross C, Krishnan AV, Malloy PJ, et al. The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. J Bone Miner Res 1998;13:1691-1699
16. Agema WRP, Monraats PS, Zwinderman AH, et al. Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era. Eur Heart J 2004;25:1163-1170
17. Li W, Nyholt DR. Marker selection by Akaike information criterion and Bayesian information criterion. Genet Epidemiol 2001;21(Suppl 1):S272-S277
18. Tregouet DA, Garelle V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 2007;23:1038-1039
19. Ranganathan P. Genetics of bone loss in rheumatoid arthritis-role of vitamin D receptor polymorphisms. Rheumatology (Oxford) 2009;48:342-346
20. Hojo Y, Ikeda U, Katsuki T, et al. Chemokine expression in coronary circulation after coronary angioplasty as a prognostic factor for restenosis. Atherosclerosis 2001;156:165-170 (Pubitemid 32429608)
21. Monraats PS, Pires NM, Schepers A, et al. Tumor necrosis factor-alpha plays an important role in restenosis development. FASEB J 2005;19:1998-2004
22. Serrano CV Jr, Ramires JA, Venturinelli M, et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol 1997;29:1276-1283
23. Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002;22:1769-1776
24. Fattori R, Piva T. Drug-eluting stents in vascular intervention. Lancet 2003;361:247-249
25. Pache J, Kastrati A, Mehilli J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 2003;41:1283-1288
26. Motohashi Y, Yamada S, Yanagawa T, et al. Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes. J Clin Endocrinol Metab 2003;88:3137-3140
27. Uitterlinden AG, Fang Y, Van Meurs JB, et al. Vitamin D receptor gene polymorphisms in relation to vitamin D related disease states. J Steroid Biochem Mol Biol 2004;89-90:187-193